Published in J Clin Microbiol on June 01, 2000
Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma. J Invest Dermatol (2011) 1.99
E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog (2011) 1.89
The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J Virol (2003) 1.81
Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog (2008) 1.44
Genomic instability and cancer: lessons learned from human papillomaviruses. Cancer Lett (2010) 1.17
Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination. Biol Blood Marrow Transplant (2008) 1.11
Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. PLoS One (2010) 1.09
Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis. J Am Acad Dermatol (2014) 1.03
Cutaneous squamous cell carcinoma and human papillomavirus: is there an association? Dermatol Surg (2012) 1.03
Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol (2007) 0.97
Vaccination of rabbits with an adenovirus vector expressing the papillomavirus E2 protein leads to clearance of papillomas and infection. J Virol (2004) 0.96
A rapidly regressing wart following biopsy. Ann Dermatol (2011) 0.94
Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types. J Virol (2011) 0.92
Exposure profiles and human papillomavirus infection in skin cancer: an analysis of 25 genus beta-types in a population-based study. J Invest Dermatol (2008) 0.92
Characterization of novel cutaneous human papillomavirus genotypes HPV-150 and HPV-151. PLoS One (2011) 0.89
Pattern of HPV infection in basal cell carcinoma and in perilesional skin biopsies from immunocompetent patients. Virol J (2012) 0.89
Development of a general-primer-PCR-reverse-line-blotting system for detection of beta and gamma cutaneous human papillomaviruses. J Clin Microbiol (2005) 0.88
UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes. Arch Virol (2004) 0.86
Bead-based multiplex genotyping of 58 cutaneous human papillomavirus types. J Clin Microbiol (2011) 0.81
Beta-papillomaviruses and psoriasis: an intra-patient comparison of human papillomavirus carriage in skin and hair. Br J Dermatol (2008) 0.81
Cutaneous epithelial tumors induced by vemurafenib involve the MAPK and Pi3KCA pathways but not HPV nor HPyV viral infection. PLoS One (2014) 0.81
Human papillomavirus in head and neck cancer. Cancers (Basel) (2014) 0.81
The role of p53 in the immunobiology of cutaneous squamous cell carcinoma. Clin Exp Immunol (2003) 0.78
Resolution of novel human papillomavirus-induced warts after HPV vaccination. Emerg Infect Dis (2014) 0.77
Anal cancer and intraepithelial neoplasia screening: A review. World J Gastrointest Surg (2016) 0.77
The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma. Clin Med Insights Oncol (2011) 0.76
Human papillomavirus infection and p16 expression in the immunocompetent patients with extragenital/extraungual Bowen's disease. Diagn Pathol (2016) 0.75
The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol (1987) 266.90
Rapid and simple method for purification of nucleic acids. J Clin Microbiol (1990) 44.73
CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene (1988) 42.41
Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta (1996) 7.79
Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med (1997) 4.00
Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol (1995) 3.26
Diagnosis of sickle cell anemia and beta-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes. N Engl J Med (1988) 2.64
Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol (1992) 2.56
Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol (1995) 2.33
Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst (1996) 2.28
Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol (1997) 2.03
Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res (1979) 1.73
Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer (1997) 1.58
Human papillomaviruses and anogenital cancers. N Engl J Med (1997) 1.44
High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol (1995) 1.35
A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol (1998) 1.23
Cutaneous warts. Clin Dermatol (1997) 1.18
Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol (1994) 1.17
Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: a unified diagnostic approach. J Clin Pathol (1998) 1.06
Role of HPV in cutaneous premalignant and malignant tumors. Clin Dermatol (1997) 1.04
Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts. Virology (1997) 0.94
Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV3 or HPV3-related types in immunosuppressed patients. J Invest Dermatol (1992) 0.94
The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation (2000) 0.90
Heterogeneity of papillomaviruses. Semin Cancer Biol (1996) 0.89
Detection of human papillomavirus DNA in PUVA-associated non-melanoma skin cancers. J Invest Dermatol (1998) 0.86
Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol (1999) 6.45
Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol (1998) 5.29
Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst (1990) 3.98
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol (1993) 3.73
Molecular epidemiology of Legionella pneumophila serogroup 1. J Clin Microbiol (1984) 2.60
Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol (1995) 2.33
Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods (1993) 2.08
Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol (1997) 2.03
Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol (2003) 1.72
Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant (2008) 1.65
Detection of leptospiral DNA by nucleic acid hybridisation with 32P- and biotin-labelled probes. J Med Microbiol (1986) 1.62
Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol (1998) 1.54
Relation between smoking and skin cancer. J Clin Oncol (2001) 1.50
Sensitivity of in situ detection with biotinylated probes of human papilloma virus type 16 DNA in frozen tissue sections of squamous cell carcinomas of the cervix. Am J Pathol (1988) 1.43
[Skin cancer and other skin disorders in patients following solid organ transplantation]. Ned Tijdschr Geneeskd (2005) 1.39
Marked differences in Betapapillomavirus DNA and antibody prevalence between patients with psoriasis and those with atopic dermatitis. Br J Dermatol (2011) 1.39
Free viral DNA in BK virus-induced hamster tumor cells. J Virol (1980) 1.38
High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol (1995) 1.35
Multifocal vulvar intraepithelial neoplasia grade III and multicentric lower genital tract neoplasia is associated with transcriptionally active human papillomavirus. Cancer (1995) 1.20
Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors. Eur J Immunol (1995) 1.19
Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology. Gynecol Oncol (1999) 1.18
Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol (1994) 1.17
The melanocortin-1-receptor gene is the major freckle gene. Hum Mol Genet (2001) 1.16
Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas. J Gen Virol (1990) 1.15
Detection of Leptospira interrogans in clinical specimens by in situ hybridization using biotin-labelled DNA probes. J Gen Microbiol (1987) 1.15
A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant (2011) 1.13
Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol (1995) 1.13
Naturally occurring BK virus variants (JL and Dik) with deletions in the putative early enhancer-promoter sequences. J Virol (1985) 1.08
DNA synthesis by isolated mitochondria. I. Effect of inhibitors and characterization of the product. Biochim Biophys Acta (1971) 1.04
Analysis of defective SV40 DNA by agarose gel electrophoresis. J Gen Virol (1975) 1.01
p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status. Oncogene (1997) 1.00
The SV40 small t antigen is essential for the morphological transformation of human fibroblasts. Virology (1989) 1.00
Human papillomavirus type 16 transcripts expressed from viral-cellular junctions and full-length viral copies in CaSki cells and in a cervical carcinoma. Virology (1991) 0.99
In situ localization of human papilloma virus type 16 DNA in a metastasis of an endocervical adenocarcinoma. Intervirology (1987) 0.98
Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: update of the EDEN Psoriasis Survey 2001-2006. Br J Dermatol (2009) 0.97
Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol (2006) 0.97
A functional NF-kappaB binding site in the human papillomavirus type 16 long control region. Virology (2000) 0.97
Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. Gynecol Oncol (1999) 0.96
Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Investig Dermatol Symp Proc (2001) 0.96
Human papillomavirus deoxyribonucleic acid detection in mildly or moderately dysplastic smears: a possible method for selecting patients for colposcopy. Am J Obstet Gynecol (1997) 0.96
Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear. J Clin Oncol (1998) 0.96
Viral oncogenesis and its role in nonmelanoma skin cancer. Br J Dermatol (2011) 0.96
The synthesis and utilization of dCDP-diglyceride by a mitochondrial fraction from rat liver. Biochim Biophys Acta (1971) 0.95
Normal findings in vulvar examination and vulvoscopy. Br J Obstet Gynaecol (1997) 0.94
Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses. J Invest Dermatol (2001) 0.92
Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series. Am J Transplant (2013) 0.91
Transduction of the E6 and E7 genes of epidermodysplasia-verruciformis-associated human papillomaviruses alters human keratinocyte growth and differentiation in organotypic cultures. J Invest Dermatol (2001) 0.90
The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation (2000) 0.90
DNA synthesis by isolated mitochondria. IV. Isolation of an intermediate containing newly synthesized DNA in full-length light strands. Biochim Biophys Acta (1972) 0.88
Evaluation of different DNA-DNA hybridisation techniques in detection of HPV 16 DNA in cervical smears and biopsies. J Med Virol (1988) 0.88
In situ hybridization for the detection of Haemophilus in sputum of patients with cystic fibrosis. Scand J Infect Dis (1987) 0.87
DNA synthesis by isolated mitochondria. II. Detection of product DNA hydrogen-bonded to closed duplex circles. Biochim Biophys Acta (1971) 0.86
Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: a need for screening? Mol Carcinog (2001) 0.86
Detection of human papillomavirus types 6 and 11 in pubic and perianal hair from patients with genital warts. J Clin Microbiol (1999) 0.86
Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg (2004) 0.86
High prevalence of cutaneous warts in elementary school children and the ubiquitous presence of wart-associated human papillomavirus on clinically normal skin. Br J Dermatol (2014) 0.85
Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol (2000) 0.85
Detection of human papillomavirus types by the polymerase chain reaction and the differentiation between high-risk and low-risk cervical lesions. Virchows Arch B Cell Pathol Incl Mol Pathol (1992) 0.85
Transcriptional regulation of human papillomavirus type 16 LCR by different C/EBPbeta isoforms. Mol Carcinog (2000) 0.85
Prevalence of antibodies against virus-like particles of Epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. J Invest Dermatol (1998) 0.84
Induction of anchorage-independent growth of human embryonic fibroblasts with a deletion in the short arm of chromosome 11 by human papillomavirus type 16 DNA. J Virol (1988) 0.84
Human papillomavirus DNA in multicentric vulvar intraepithelial neoplasia. Int J Gynecol Pathol (1998) 0.83
Application of the NASBA nucleic acid amplification method for the detection of human papillomavirus type 16 E6-E7 transcripts. J Virol Methods (1995) 0.83
Diagnosis of progressive multifocal leucoencephalopathy by hybridisation techniques. J Clin Pathol (1989) 0.83
Human papillomavirus DNA after treatment of cervical dysplasia: low prevalence in normal cytologic smears. Cancer (1996) 0.82
HPV-DNA is not detectable in outgrowing cells from explant cultures of skin lesions established at the air-liquid-interface. J Med Virol (2000) 0.82
Basal cell carcinoma on the dorsum of the hand: report of 11 cases. J Eur Acad Dermatol Venereol (2000) 0.81
Competition inhibition of cytotoxic T-lymphocyte (CTL) lysis, a more sensitive method to identify candidate CTL epitopes than induction of antibody-detected MHC class I stabilization. Immunol Lett (1996) 0.81
Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy. Clin Toxicol (Phila) (2008) 0.81
Clearance of cervical human papillomavirus infection by treatment for cervical dysplasia. Sex Transm Dis (1997) 0.81
Human papillomavirus type 5 is commonly present in immunosuppressed and immunocompetent individuals. Br J Dermatol (1999) 0.81
Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitope. J Immunother (1998) 0.80
Pain identifies squamous cell carcinoma in organ transplant recipients: the SCOPE-ITSCC PAIN study. Am J Transplant (2014) 0.80
Prevalence and multiplicity of cutaneous beta papilloma viruses in plucked hairs depend on cellular DNA input. J Virol Methods (2009) 0.80
Modulation of the human papillomavirus type 16 induced transformation and transcription by deletion of loci on the short arm of human chromosome 11 can be mimicked by SV40 small t. Virology (1992) 0.80
Detection of oncogenic HPV DNA by a consensus polymerase chain reaction method in genital carcinomas in twenty women in Barbados. West Indian Med J (1993) 0.80
DNA synthesis by isolated mitochondria. 3. Characterization of D-loop DNA, a novel intermediate in mtDNA synthesis. Biochim Biophys Acta (1971) 0.80
Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin. Br J Dermatol (2005) 0.79
Trends of skin diseases in organ-transplant recipients transplanted between 1966 and 2006: a cohort study with follow-up between 1994 and 2006. Br J Dermatol (2009) 0.79
Point and period prevalences of eczema in rural and urban schoolchildren in Ghana, Gabon and Rwanda. J Eur Acad Dermatol Venereol (2011) 0.79
Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions. J Med Virol (1995) 0.79
Lesional HPV types of cutaneous warts can be reliably identified by surface swabs. J Clin Virol (2011) 0.78
Characterization of skin lesions induced by skin-tropic α- and β-papillomaviruses in a patient with epidermodysplasia verruciformis. Br J Dermatol (2014) 0.77
Antibodies to human papillomavirus type 16 E7 related to clinicopathological data in patients with cervical carcinoma. J Clin Pathol (1995) 0.77
Morphological transformation by early region human polyomavirus BK DNA of human fibroblasts with deletions in the short arm of one chromosome 11. J Gen Virol (1988) 0.77
Risk factors for HPV detection in archival Pap smears. A population-based study from Greenland and Denmark. Eur J Cancer (1998) 0.77
Prevalence and causative fungal species of tinea capitis among schoolchildren in Gabon. Mycoses (2010) 0.77
Inhibition of human papillomavirus-16 long control region activity by interferon-gamma overcome by p300 overexpression. Mol Carcinog (2001) 0.77
The early enhancer-promoter of BKV and host range for transformation. Intervirology (1987) 0.77
Regulation of human papillomavirus type 16 (HPV-16) transcription by loci on the short arm of chromosome 11 is mediated by the TATAAAA motif of the HPV-16 promoter. J Gen Virol (1993) 0.77
Capillary gas chromatography of urine samples in diagnosing cerebrotendinous xanthomatosis. Arch Dermatol (1986) 0.76